FDA 483 - Post Oak Innovations, Inc. - October 13, 2023

An FDA inspection of Post Oak Innovations, Inc. in Dallas, TX, revealed significant deficiencies in their quality system. The firm failed to adequately establish and verify corrective and preventive actions, maintain proper records for document changes, and ensure acceptable contractor records. These findings indicate a need for comprehensive improvements in their quality management processes.